Abbott Laboratories (ABT) is a publicly traded Healthcare sector company. As of September 11, 2026, ABT trades at $101.97 with a market cap of $182.09B and a P/E ratio of 33.48. ABT moved -1.53% today. Year to date, ABT is -16.77%; over the trailing twelve months it is -20.10%. Its 52-week range spans $81.97 to $141.23. Analyst consensus is strong buy with an average price target of $124.33. Rallies surfaces ABT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Abbott Laboratories (ABT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABT moved -1.53% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $101.97 |
| Market Cap | $182.09B |
| P/E Ratio | 33.48 |
| EPS | $3.10 |
| Dividend Yield | 0.63% |
| 52-Week High | $141.23 |
| 52-Week Low | $81.97 |
| Volume | 2.64M |
| Avg Volume | 0 |
| Revenue (TTM) | $46.59B |
| Net Income | $5.42B |
| Gross Margin | 56.61% |
15 analysts cover ABT: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $124.33.